Welcome to Drug and Alcohol Treatment
| ||
Drug Patient Article
This is a selection made from among articles on Drug Patient. For a permanent link to this article, or to bookmark it for future reading, click here.
Drug Addiction Rehabilitation: Tailoring The Treatment To The Need
from:by Judy Wellsworth
The intensity of drug addiction rehabilitation required by different addicts will vary according to the severity of their addictions. When addicts admit themselves, or are forcibly admitted, to drug addiction rehabilitation facilities, their physical conditions are evaluated so that an appropriate treatment can be determined. There are different drug addiction rehabilitation programs designed to treat the different levels of addiction.Outpatient Treatmenr and DetoxThere are, at the lowest level of drug addiction rehabilitation, intervention and short duration programs, which do not involve any physical treatment. They include court-ordered attendance at classes on the dangers of driving while intoxicated or visits to rehab units for teens caught using drugs or alcohol who has not yet become addicts. They are designed to steer people off the road to addiction before they have traveled to far down it.Detoxification is the second level of drug addiction rehabilitation; just the opposite of short-term intervention, detoxification treats only the physical nature of addiction. The addict is admitted to a facility, remains until he or she is free of the effects of whatever substances caused the admission, and is released. Inpatient TreatmentThe most comprehensive of all the drug addiction rehabilitation programs is inpatient treatment. Inpatient drug addiction rehabilitation requires addicts to take up residence in the facility where they receive their treatment, and the amount of time they stay will depend on how hard they work on confronting their addictions and learning healthier patterns of behavior. Inpatient drug addiction rehabilitation will first include detoxification, with or without the use of sedatives and pain medications; their inclusion will depend both on whether the addict’s system can handle any more chemicals, and whether those running the program believe going “cold turkey” when withdrawing is the best deterrent to future substance abuse.Once the detoxification is over, the addicts will spend their days learning to take responsibility by having jobs assigned to them; going to individual and group counseling sessions, and getting at the emotional causes underlying their dependencies. The process can last for a month of for a year, depending on the severity of the addiction. Inpatient drug addiction rehabilitation is a last resort.Therapeutic techniques in inpatient facilities may include journaling so that the addicts can learn both self-observation skills and how to recognize the situations in which their cravings for drugs are triggered.Choosing the appropriate drug addiction rehabilitation is a matter of balancing the severity of the addiction with the addict’s desire for recovery.
You can also find more information at Drug Addiction Treatment and Drug Addiction Centers. Drugtreatmentinfo.org is a comprehensive resource to known more about drug addiction.
Drug Patient Specific links
Drug Patient News
Altheos begins patient dosing in glaucoma drug trial - Pharmaceutical Business Review
Altheos begins patient dosing in glaucoma drug trial Pharmaceutical Business Review Altheos has announced the dosing of first patient in a Phase 2a clinical trial of its lead investigational candidate, ATS907. ATS907 is a Rho kinase (ROCK)-selective inhibitor in development as a next-generation eye drop for the reduction of elevated ... Altheos Announces Initiation of Phase 2a Clinical Trial for its Lead Glaucoma ... |
FDA panel says Amgen drug did not provide meaningful benefit for prostate ... - Washington Post
 Daily Gossip | FDA panel says Amgen drug did not provide meaningful benefit for prostate ... Washington Post WASHINGTON — A panel of cancer experts voted against a new use for Amgen's Xgeva in prostate cancer on Wednesday, saying the drug's ability to slow the spread of the disease did not translate into meaningful benefits for patients. FDA panel votes against wider use of Amgen drug FDA Limits Use Of Amgen Inc's drug Xgeva When Passing Your Clinical Trial Isn't Enough |
FDA outlines path for lower-priced biotech drugs - USA TODAY
 USA TODAY | FDA outlines path for lower-priced biotech drugs USA TODAY "These draft documents are designed to help industry develop biosimilar versions of currently approved biological products, which can enhance competition and may lead to better patient access and lower cost to consumers," FDA's drug division director ... Generic insulin, cancer therapies? They're coming |
OptiNose Announces First Patient Enrolled in Phase III Study of Sumatriptan ... - MarketWatch (press release)
OptiNose Announces First Patient Enrolled in Phase III Study of Sumatriptan ... MarketWatch (press release) The trial, named TARGET (AssessmenT of Delivery of Drug via A Novel Device to the IntRanasal Cavity for MiGraine PatiEnTs) will evaluate the safety and efficacy of this novel product -- specifically assessing the ability to offer rapid pain relief, ... |
OptiNose enrolls first patient in Phase III intranasal technology trial - Pharmaceutical Business Review
OptiNose enrolls first patient in Phase III intranasal technology trial Pharmaceutical Business Review OptiNose has enrolled the first patient in a Phase III study involving the intranasal delivery of Sumatriptan powder using its bi-directional technology. The randomized double-blind placebo-controlled parallel group AssessmenT of Delivery of Drug via A ... OptiNose Announces First Patient Enrolled in Phase III Study of Sumatriptan ... |
Mental health patients using drugs/alcohol - Ninemsn
 ABC Online | Mental health patients using drugs/alcohol Ninemsn A report into the disappearance of sex killer Trent Jennings from Morisset Hospital had failed to address patients' access to illegal drugs and alcohol, victims advocates say. Howard Brown, of the Victims of Crime Assistance League, says mental health ... Victim calls for better monitoring of mental health patients |
Health IT Factors Into Leapfrog's Hospitals Rankings - InformationWeek
Health IT Factors Into Leapfrog's Hospitals Rankings InformationWeek By Marianne Kolbasuk McGee InformationWeek The Leapfrog Group has named the nation's top hospitals for 2011, and the list shines a spotlight on how health IT can help improve patient care--even preventing medical errors that can lead to adverse drug ... |
Panel Nixes AML Indication for Dacogen - MedPage Today
Panel Nixes AML Indication for Dacogen MedPage Today Panelists were largely concerned about the failure of the drug in a randomized trial that compared it with standard therapy -- the drug failed to improve overall survival. "Elderly leukemia patients are desperate for new drugs to prolong survival, ... FDA Panel Votes Against Astex Acute Myeloid Leukemia Drug Dacogen; Shares Down |
New CF Drug Targets Protein - Harvard Crimson
New CF Drug Targets Protein Harvard Crimson “This represents a transformation in the care of the subset of the patients that have CF. We're happy with the way this drug has been able to improve their lives.” As an example of personalized medicine, Wright said this treatment is a “very highly ... |
Honesty with Patients is Optional with Some Doctors - Technorati
 Technorati | Honesty with Patients is Optional with Some Doctors Technorati In 2013, patients will be able to look up data on their doctors' financial ties with drug and device manufacturers, thanks to the new Affordable Care Act. Tentative regulations setting up the reporting system were published in December by the Food and ... |